
Pharma is built to overcome, but focus on fundamentals remains key.
Arda Ural, Ph.D., is the Americas Industry Markets Leader for Health Sciences and Wellness at Ernst & Young LLP (EY). Arda oversees the life sciences team that covers industry mergers and acquisitions.
Pharma is built to overcome, but focus on fundamentals remains key.
A recent analysis of the biotech market shows promising signs.
The recent flurry of Q1 earnings reports offer a unique opportunity to assess the real-time impacts of COVID-19 on the sector.
Considerations for biopharma to transform itself beyond the COVID-19 crisis, by Arda Ural.
Published: May 21st 2021 | Updated:
Published: July 6th 2023 | Updated:
Published: May 28th 2020 | Updated: